181 Tuberculosis
• Despite advances in diagnosis and therapy, tuberculosis (TB) remains a leading cause of death worldwide.
• TB begins as a primary infection (usually in the lung, but other organ systems may be involved) that enters a latent period.
• Immunocompromised patients are at increased risk of reactivation of the disease and the development of active TB.
• The presentation of TB can be very broad and should remain in the differential diagnosis in all patients who present with systemic signs of infection.
• Therapy for TB should include multiple drugs to which the mycobacterium is susceptible and should continue for at least 6 to 12 months.
• Because of the risk of multidrug-resistant TB, an initial four-drug regimen with isoniazid, rifampin, ethambutol, and pyrazinamide is recommended.
Pathophysiology
Mycobacterium tuberculosis is a small, slow-growing bacterium that is transmitted by inhalation of droplet nuclei. As infected persons talk, cough, or sneeze, numerous nuclei are expelled into the surrounding air. Only a few inhaled droplets are needed to infect, so an increased length of exposure to the pathogen and the number of bacilli present correlate with infectivity.1
A delayed hypersensitivity response uses cytotoxic killer CD8 suppressor T cells to kill the other nonactivated macrophages with bacilli. This process creates local tissue destruction and the formation of a caseating granuloma. In immunocompromised patients, this caseous center may expand and then calcify to form a Ghon complex in the lung. If the infection is uncontrolled, primary tuberculous pneumonia may ensue, or infection may spread through blood and lymph, with resulting disseminated TB.2
Classic Presentation
The symptom constellation of cough, night sweats, and hemoptysis, commonly associated with TB, is of little benefit in the early identification of disease because TB often has no early symptoms. Late symptoms are wide ranging and do not always involve the respiratory tract. Extrapulmonary manifestations of TB are seen in 20% of patients when the host is immunocompetent and are even more common when the host is immunocompromised.3 In patients with one or more risk factors for TB (Table 181.1 and Box 181.1),4 a detailed history helps to refine the pretest probability for the diagnosis of TB.
RACE OR ETHNICITY | RATE* |
---|---|
White, non-Hispanic | 1.4 |
American Indian/Alaska Native | 8.0 (5.7) |
Hispanic | 10.5 (7.5) |
Black, non-Hispanic | 11.5 (8.2) |
Asian/Pacific Islander | 29.4 (21.0) |
* Numbers in parentheses represent risk for tuberculosis compared with white non-Hispanics.
From American Thoracic Society, Centers for Disease Control and Prevention, Infectious Diseases Society of America. Treatment of tuberculosis. MMWR Recomm Rep 2003:52:1-77 [erratum appears in MMWR Recomm Rep 2005;53:1203; dosage error in text].
Box 181.1
Populations at Risk for Contracting Tuberculosis
Persons with human immunodeficiency infection
Persons with exposure to a known case
Persons of Asian, African, or Latin American descent
Adapted from American Thoracic Society, Centers for Disease Control and Prevention, Infectious Diseases Society of America. Controlling tuberculosis in the United States. Am J Respir Crit Care Med 2005;172:1169-1227.
Early stages of infection are most often asymptomatic in the normal host. Unless cell-mediated immunity is impaired, symptoms may manifest only after reactivation of the infection. Patients may present with a combination of systemic symptoms including cough, fatigue, fever, anorexia, malaise, and weight loss. An indolent cough that has progressed over more than 2 weeks should raise the clinical suspicion of pulmonary TB.5 Hemoptysis signifies erosion into the bronchial tree and is unlikely to be an early symptom of pulmonary TB. When the clinical suspicion is raised, the physical findings in pulmonary TB may include fever, pleural effusion, focal pneumonic ausculatory findings, and adenopathy.
Variations
• Diffuse adenopathy of the neck (scrofula)
• Recurrent urinary tract infections, scrotal mass, prostatitis, epididymitis, or orchitis (genitourinary TB)
• Headache, fever, meningeal signs, or altered mental status (TB meningitis)
• Focal neurologic deficits, cranial nerve abnormalities, cerebellar dysfunction, or seizure (central nervous system tuberculomas)
• Joint or spinal pain (Pott disease)
Differential Diagnosis
Depending on the clinical symptoms at presentation, TB may mimic numerous systemic diseases. Radiographic findings, sputum smears, and skin tests help in the diagnosis of TB. The “gold standard” diagnostic test is culture, and results may not be available for several weeks (Table 181.2).
Pulmonary Tuberculosis |
HIV, Human immunodeficiency virus.